Completed PHASE2 INTERVENTIONAL 2-arm NCT00556361

Use of Ketamine Prior to Cardiopulmonary Bypass in Children

Sponsor: Arkansas Children's Hospital Research Institute

Updated 5 times since 2017 Last updated: Nov 9, 2007 Started: Jul 31, 2004 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00556361, this PHASE2 trial focuses on Ventricular Septal Defect and remains completed. Sponsored by Arkansas Children's Hospital Research Institute, it has been updated 5 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2
Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Arkansas Children's Hospital Research Institute

Data source: Arkansas Children's Hospital Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Little Rock, United States